Cardiopulmonary Exercise Testing Market: Information by Product (Cardiopulmonary Exercise Testing (CPET) Systems, Single-Photon Emission Computed Tomography (SPECT), Echocardiogram, Pulse Oximeters, Stress Blood Pressure Monitors and others), by End User (Hospitals & Clinics, Diagnostic Centers, Ambulatory Surgical Centers and others) and by Region (Americas, Europe, Asia-Pacific and the Middle East Africa) - Forecast till 2030
ID: MRFR/HC/5163-CR | 157 Pages | Published By Rahul Gotadki on July 2019
1 Report Prologue
2 Introduction
2.1 Definition 14
2.2 Scope of the Study 14
2.3 Research Objective 14
2.4 Assumptions & Limitations 14
2.4.1 Assumptions 14
2.4.2 Limitations 14
2.4.3 Market Structure 15
3 Research Methodology
3.1 Primary Research Methodology 17
3.2 Secondary Research Methodology 18
3.3 Market Size Estimation 19
3.4 Forecast Model 19
4 Market Dynamics
4.1 Introduction 22
4.2 Drivers 23
4.2.1 Rising Geriatric Population 23
4.2.2 Rising Cardiovascular Diseases 23
4.2.3 Research and Development 23
4.3 Restraints 24
4.3.1 High Cost 24
4.3.2 Regulatory Affairs 24
4.4 Opportunity 24
4.4.1 Entering Developing Markets 24
5 Market Factor Analysis
5.1 Porter’s Five Forces Model 26
5.1.1 Bargaining Power of Suppliers 26
5.1.2 Bargaining Power of Buyers 26
5.1.3 Threat of New Entrants 26
5.1.4 Threat of Substitutes 27
5.1.5 Intensity of Rivalry 27
5.2 Price Analysis 27
5.3 Investment Opportunity Analysis 27
5.4 Value Chain Analysis 28
5.4.1 Supporting Activity 28
5.4.2 Inbound Logistics 28
5.4.3 Operations 28
5.4.4 Marketing and Sales 28
5.4.5 Outbound Logistics 28
5.4.6 Customer Services 29
6 Cardiopulmonary Exercise Testing Market, by Product
6.1 Introduction 31
6.2 Cardiopulmonary Exercise Testing (CPET) Systems 33
6.3 Single-Photon Emission Computed Tomography (SPECT) 34
6.4 Echocardiogram 34
6.5 Pulse Oximeters 35
6.6 Stress Blood Pressure Monitors 35
7 Cardiopulmonary Exercise Testing Market, by End-User
7.1 Introduction 37
7.2 Hospitals and Clinics 38
7.3 Diagnostic Centers 38
7.4 Ambulatory Centers 39
7.5 Others 39
8 Global Cardiopulmonary Exercise Testing Market, by Region
8.1 Introduction 41
8.2 Americas 42
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.2.1 North America 44
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.2.1.1 US. 46
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.2.1.2 Canada 47
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.2.2 South America 48
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3 Europe 49
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1 Western Europe 51
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.1 Germany 53
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.2 France 54
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.3 UK 55
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.4 Italy 56
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.5 Spain 57
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.1.6 Rest of Western Europe 58
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.3.2 Eastern Europe 59
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4 Asia-Pacific 60
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.1 Japan 62
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.2 China 63
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.3 India 64
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.4 Australia 65
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.5 South Korea 66
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.4.6 Rest of Asia-Pacific 67
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.5 Middle East and Africa 68
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.5.1 Middle East 70
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
8.5.2 Africa 71
Cardiopulmonary Exercise Testing Market, by Product
Cardiopulmonary Exercise Testing Market, by End-User
9 Company Landscape
9.1 Company Share Analysis 73
10 Company Profiles
10.1 Cardinal Health 75
10.1.1 Company Overview 75
10.1.2 Financial Overview 75
10.1.3 Products Offering 76
10.1.4 Key Developments 76
10.1.5 SWOT Analysis 76
10.1.6 Key Strategy 76
10.2 COSMED SRL 77
10.2.1 Company Overview 77
10.2.2 Financial Overview 77
10.2.3 Products Offering 77
10.2.4 Key Developments 77
10.2.5 SWOT Analysis 78
10.2.6 Key Strategy 78
10.3 GE Healthcare 79
10.3.1 Company Overview 79
10.3.2 Financial Overview (Healthcare Segment) 79
10.3.3 Products Offering 80
10.3.4 Key Developments 80
10.3.5 SWOT Analysis 80
10.3.6 Key Strategy 81
10.4 Halma PLC 82
10.4.1 Company Overview 82
10.4.2 Financial Overview 82
10.4.3 Products Offering 83
10.4.4 Key Developments 83
10.4.5 SWOT Analysis 83
10.4.6 Key Strategy 83
10.5 Hill-Rom Holdings, Inc. 84
10.5.1 Company Overview 84
10.5.2 Financial Overview 84
10.5.3 Products Offering 85
10.5.4 Key Developments 85
10.5.5 SWOT Analysis 85
10.5.6 Key Strategy 85
10.6 Koninklijke Philips NV. 86
10.6.1 Company Overview 86
10.6.2 Financial Overview 86
10.6.3 Products Offering 87
10.6.4 Key Developments 88
10.6.5 SWOT Analysis 88
10.6.6 Key Strategy 88
10.7 MGC Diagnostics Corporation 89
10.7.1 Company Overview 89
10.7.2 Financial Overview 89
10.7.3 Products Offering 89
10.7.4 Key Developments 89
10.7.5 SWOT Analysis 90
10.7.6 Key Strategy 90
10.8 NIHON KOHDEN CORPORATION 91
10.8.1 Company Overview 91
10.8.2 Financial Overview 91
10.8.3 Products Offering 92
10.8.4 Key Developments 92
10.8.5 SWOT Analysis 92
10.8.6 Key Strategy 92
10.9 Schiller AG 93
10.9.1 Company Overview 93
10.9.2 Financial Overview 93
10.9.3 Products Offering 93
10.9.4 Key Developments 94
10.9.5 SWOT Analysis 94
10.9.6 Key Strategy 94
10.10 Masimo Corporation 95
10.10.1 Company Overview 95
10.10.2 Financial Overview 95
10.10.3 Products Offering 96
10.10.4 Key Developments 96
10.10.5 SWOT Analysis 96
10.10.6 Key Strategy 97
10.11 Vyaire Medical, Inc. 98
10.11.1 Company Overview 98
10.11.2 Financial Overview 98
10.11.3 Products Offering 98
10.11.4 Key Developments 98
10.11.5 SWOT Analysis 99
10.11.6 Key Strategy 99
11 Appendix
11.1 Discussion Blue Print 101
11.2 References 102
12 List of Tables
TABLE 1 PRIMARY INTERVIEWS 18
TABLE 2 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 31
TABLE 3 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR CARDIOPULMONARY EXERCISE TESTING (CPET) SYSTEMS,
BY REGION, 2020–2027 (USD MILLION) 32
TABLE 4 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR SINGLE–PHOTON EMISSION COMPUTED
TOMOGRAPHY (SPECT), BY REGION, 2020–2027 (USD MILLION) 33
TABLE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR ECHOCARDIOGRAM, BY REGION, 2020–2027 (USD MILLION) 33
TABLE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR PULSE OXIMETERS, BY REGION, 2020–2027 (USD MILLION) 34
TABLE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR STRESS BLOOD PRESSURE MONITORS, BY REGION,
2020–2027 (USD MILLION) 34
TABLE 8 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 36
TABLE 9 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR HOSPITALS AND CLINICS, BY REGION,
2020–2027 (USD MILLION) 37
TABLE 10 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR DIAGNOSTIC CENTERS, BY REGION,
2020–2027 (USD MILLION) 37
TABLE 11 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET FOR AMBULATORY CENTERS, BY REGION,
2020–2027 (USD MILLION) 38
TABLE 12 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 40
TABLE 13 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 41
TABLE 14 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 42
TABLE 15 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 42
TABLE 16 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 43
TABLE 17 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 44
TABLE 18 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 44
TABLE 19 US CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 45
TABLE 20 US CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 45
TABLE 21 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 46
TABLE 22 CANADA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 46
TABLE 23 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 47
TABLE 24 SOUTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 47
TABLE 25 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 48
TABLE 26 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 49
TABLE 27 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 49
TABLE 28 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 50
TABLE 29 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 51
TABLE 30 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 51
TABLE 31 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 52
TABLE 32 GERMANY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 52
TABLE 33 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 53
TABLE 34 FRANCE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 53
TABLE 35 UK CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 54
TABLE 36 UK CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 54
TABLE 37 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 55
TABLE 38 ITALY CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 55
TABLE 39 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 56
TABLE 40 SPAIN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 56
TABLE 41 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 57
TABLE 42 REST OF WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 57
TABLE 43 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 58
TABLE 44 EASTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 58
TABLE 45 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020–2027 (USD MILLION) 59
TABLE 46 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 60
TABLE 47 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 60
TABLE 48 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 61
TABLE 49 JAPAN CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 61
TABLE 50 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 62
TABLE 51 CHINA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 62
TABLE 52 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 63
TABLE 53 INDIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 63
TABLE 54 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 64
TABLE 55 AUSTRALIA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 64
TABLE 56 SOUTH KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 65
TABLE 57 SOUTH KOREA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 65
TABLE 58 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 66
TABLE 59 REST OF ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 66
TABLE 60 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020–2027 (USD MILLION) 67
TABLE 61 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 68
TABLE 62 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 68
TABLE 63 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 69
TABLE 64 MIDDLE EAST CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 69
TABLE 65 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020–2027 (USD MILLION) 70
TABLE 66 AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY END–USER 2020–2027 (USD MILLION) 70
13 List of Figures
FIGURE 1 TOP-DOWN & BOTTOM-UP APPROACHES 19
FIGURE 2 MARKET DYNAMICS: ANALYSIS OF THE GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET 21
FIGURE 3 PORTER’S FIVE FORCES MODEL 25
FIGURE 4 VALUE CHAIN: CARDIOPULMONARY EXERCISE TESTING MARKET 27
FIGURE 5 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY PRODUCT 2020 & 2027 (USD MILLION) 30
FIGURE 6 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY END-USER 2020 & 2027 (USD MILLION) 36
FIGURE 7 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 & 2027 (USD MILLION) 40
FIGURE 8 AMERICAS CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 41
FIGURE 9 NORTH AMERICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020 (%) 43
FIGURE 10 EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 48
FIGURE 11 WESTERN EUROPE CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020 (%) 50
FIGURE 12 ASIA-PACIFIC CARDIOPULMONARY EXERCISE TESTING MARKET, BY COUNTRY 2020(%) 59
FIGURE 13 MIDDLE EAST & AFRICA CARDIOPULMONARY EXERCISE TESTING MARKET, BY REGION 2020 (%) 67
FIGURE 14 GLOBAL CARDIOPULMONARY EXERCISE TESTING MARKET COMPANY SHARE ANALYSIS, 2020 (%) 72
